Literature DB >> 2499134

The role of the spleen in the neuroinvasion of scrapie in mice.

R H Kimberlin1, C A Walker.   

Abstract

The pathogenesis of 139A scrapie has been studied in CW mice infected intraperitoneally (i.p.), intravenously (i.v.) or subcutaneously (s.c.). In mice splenectomised before i.p. infection, the evidence points to a neuroinvasive pathway from visceral lymph nodes (and other sites of scrapie replication in the peritoneum) to the thoracic spinal cord. However, in non-splenectomised mice, the major neuroinvasive pathway is clearly from spleen to thoracic cord because i.p. incubation periods are shorter and replication in the thoracic cord starts correspondingly earlier than in splenectomised mice. Studies of splenectomy at different times after i.p. infection show that pathogenesis becomes independent of the spleen once infection has initiated scrapie replication in the spinal cord. The simplest interpretation of all the evidence favours the spread of scrapie infection along splenic nerve fibres to the thoracic spinal cord. The same neuroinvasive pathway is suggested by the findings using the s.c. and i.v. routes of infection. In addition it was found that the 100-fold greater efficiency of infection by the i.v. compared to the i.p. route was entirely dependent on the spleen, because splenectomy before i.v. infection reduced its efficiency to the same as that found in i.p. infected (non-splenectomised) mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499134     DOI: 10.1016/0168-1702(89)90039-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  37 in total

1.  Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment.

Authors:  Nicole C Kaneider; Arthur Kaser; Stefan Dunzendorfer; Herbert Tilg; Christian J Wiedermann
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2010-03-18       Impact factor: 4.304

3.  Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.

Authors:  P S Kaeser; M A Klein; P Schwarz; A Aguzzi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Temporary depletion of CD11c+ dendritic cells delays lymphoinvasion after intraperitonal scrapie infection.

Authors:  Sevda Cordier-Dirikoc; Joëlle Chabry
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Interaction of scrapie agent and cells of the lymphoreticular system.

Authors:  R I Carp; S M Callahan; B A Patrick; P D Mehta
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 6.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

7.  Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination.

Authors:  Sílvia Sisó; Lorenzo González; Martin Jeffrey
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-23

8.  Immunization delays the onset of prion disease in mice.

Authors:  Einar M Sigurdsson; David R Brown; Maki Daniels; Richard J Kascsak; Regina Kascsak; Richard Carp; Harry C Meeker; Blas Frangione; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie.

Authors:  Randi Sørby; Lars Austbø; Charles McL Press; Grethe Skretting; Thor Landsverk; Arild Espenes
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Levels of abnormal prion protein in deer and elk with chronic wasting disease.

Authors:  Brent L Race; Kimberly D Meade-White; Anne Ward; Jean Jewell; Michael W Miller; Elizabeth S Williams; Bruce Chesebro; Richard E Race
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.